Show simple item record

dc.contributor.authorHemmati-Dinarvand, M
dc.contributor.authorTaheraghdam, A
dc.contributor.authorMota, A
dc.contributor.authorZununi Vahed, S
dc.contributor.authorSamadi, N
dc.date.accessioned2018-08-26T08:57:56Z
dc.date.available2018-08-26T08:57:56Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54631
dc.description.abstract[No abstract available]
dc.language.isoEnglish
dc.relation.ispartofClinical Biochemistry
dc.subjectbiological marker
dc.subjectferritin
dc.subjectreduced nicotinamide adenine dinucleotide phosphate oxidase 1
dc.subjectselenium
dc.subjecturic acid
dc.subjectferritin
dc.subjectnicotinamide adenine dinucleotide phosphate
dc.subjectdiagnostic value
dc.subjectenzyme blood level
dc.subjectferritin blood level
dc.subjecthuman
dc.subjectLetter
dc.subjectParkinson disease
dc.subjectpatient monitoring
dc.subjectpredictive value
dc.subjectpriority journal
dc.subjectselenium blood level
dc.subjectsensitivity and specificity
dc.subjecturic acid blood level
dc.subjectParkinson disease
dc.subjectserum
dc.subjectFerritins
dc.subjectHumans
dc.subjectNADP
dc.subjectParkinson Disease
dc.subjectSerum
dc.titleIn response to a letter to Editor by Vivek Kumar Garg., et al. on our paper: "Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease"‌. Hemmati-Dinarvand, M., et al. 2017; 50 (18):1087-1092
dc.typeArticle
dc.citation.volume56
dc.citation.spage118
dc.citation.epage119
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/j.clinbiochem.2018.04.023


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record